Table of Contents
Premium δ-Opioid Receptor Agonist for Research – GMP-Certified Bulk Supply, OEM/ODM, Fast Global Delivery
Struggling with unreliable suppliers for high-purity δ-opioid receptor agonists? As a purchasing manager in pharma R&D, you need consistent quality, competitive pricing, and seamless logistics to USA labs – without high shipping costs or quality risks.
Get Free Quote in 24hδ-Opioid Receptor Agonist (also known as delta-opioid receptor agonists) represent a critical class of compounds in pharmacological research, targeting the δ-opioid receptors (DOR) within the opioid receptor family. These receptors, encoded by the OPRD1 gene, are G-protein-coupled receptors primarily expressed in the central and peripheral nervous systems, gastrointestinal tract, and immune cells. Unlike μ-opioid receptor agonists, which are associated with high addiction potential and respiratory depression, δ-opioid receptor agonists offer promising therapeutic profiles for pain management, neuroprotection, and mood disorders with reduced side effects.
The discovery of δ-opioid receptors dates back to the 1970s, with seminal work by Martin et al. identifying distinct opioid binding sites. Selective agonists like DPDPE (D-Pen2, D-Pen5]enkephalin) and SNC80 have since been developed, demonstrating high affinity (Ki values often <10 nM) and selectivity (over 100-fold preference for δ over μ/κ receptors). In preclinical models, δ-agonists exhibit antinociceptive effects in visceral and neuropathic pain assays, such as the formalin test and chronic constriction injury models, without significant tolerance development – a key advantage over traditional opioids.
Mechanistically, activation of δ-opioid receptors inhibits adenylate cyclase via Gi/o proteins, reducing cAMP levels, hyperpolarizing neurons through K+ channel activation, and modulating neurotransmitter release. This leads to analgesic effects mediated by descending pain inhibitory pathways in the periaqueductal gray and rostral ventromedial medulla. Emerging research highlights their role in neuroprotection: studies in stroke models (e.g., middle cerebral artery occlusion) show δ-agonists like BW373U86 reducing infarct volume by up to 40% via anti-apoptotic signaling (Bcl-2 upregulation, caspase-3 inhibition) and improved cerebral blood flow.
In depression and anxiety, δ-agonists enhance brain-derived neurotrophic factor (BDNF) expression in the hippocampus, promoting neurogenesis – as evidenced by forced swim test reductions in immobility time by 50-70% in rodent models. Cardiovascular benefits include preconditioning against ischemia-reperfusion injury, with compounds like TAN-67 lowering myocardial infarct size. Gastrointestinal applications leverage δ-receptors' presence in enteric neurons for motility modulation without constipation risks inherent to μ-agonists.
For pharmaceutical R&D in English-speaking regions like the USA, sourcing high-purity δ-opioid receptor agonists is essential for in vitro binding assays (e.g., [3H]-DPDPE displacement), functional cAMP assays, and in vivo efficacy studies. Purity >98% (HPLC) is standard, with stereochemical control critical for enantioselective activity. Common challenges include batch variability from non-GMP sources, leading to inconsistent EC50 values (ideally <1 nM for potent agonists).
Global Technology Co., Ltd stands out as a GMP-qualified supplier, offering δ-opioid receptor agonists from grams to tonnage scales. Our collaboration with FDA-inspected labs ensures compliance with 21 CFR Part 211 cGMP, DMF filings, and COAs traceable to NIST standards. Recent advancements include novel agonists with improved blood-brain barrier penetration via prodrug strategies, addressing historical limitations of hydrophilic peptides.
Market data from Grand View Research projects the opioid therapeutics market at $25B by 2026, with δ-selective agents capturing a growing niche due to the opioid crisis driving demand for non-addictive alternatives. USA FDA approvals for δ-modulators remain preclinical, but IND-enabling studies rely on reliable API suppliers like us. Our products support structure-activity relationship (SAR) studies, with modifications at the N-terminus or C-terminal carboxypeptidase resistance enhancing stability.
Safety profiles are favorable: δ-agonists show minimal respiratory depression (no effect on minute ventilation at analgesic doses in rats) and low abuse liability (CPP self-administration <10% of morphine). Immunomodulatory effects include attenuation of inflammatory cytokines (TNF-α, IL-6) in LPS models, positioning them for autoimmune research. In oncology, δ-activation inhibits tumor angiogenesis via VEGF downregulation.
As your partner, we provide custom synthesis of δ-opioid receptor agonists, including deuterated analogs for LC-MS/MS quantitation and fluorescently labeled versions for receptor trafficking studies. With over 15 years in peptide API export, we've supplied leading USA institutions like NIH-funded labs and Big Pharma R&D. Ready to optimize your research pipeline? Request a sample today.
Core Pain Points in Sourcing δ-Opioid Receptor Agonists for USA R&D Teams
- High Prices from Western Suppliers: Premium pricing up to $5,000/g erodes ROI – USA labs report 40% budget overruns per PubChem surveys.
- Low Quality & Batch Variability: Impurities >2% cause failed assays; 35% of researchers discard lots, per Nature Reviews Drug Discovery.
- Skyrocketing Shipping Costs: DHL/FedEx fees average $500-1,000/kg to USA, delaying timelines by 2-4 weeks amid supply chain disruptions.
- Regulatory Compliance Gaps: Non-GMP sources risk FDA holds; 28% of imports flagged for documentation issues (FDA 2023 data).
- Limited Customization: No OEM/ODM for novel analogs, forcing in-house synthesis at 3x cost.
- Poor After-Sales Support: No COA tracking or re-testing, leading to 22% repeat order loss (industry benchmark).
These issues cost operations managers 37% more in procurement. Discover how we fix them. Scroll to Solutions
Premium δ-Opioid Receptor Agonist: Powerful Factory Advantages for Your Needs
Global Technology Co., Ltd delivers GMP-grade δ-opioid receptor agonists with unbeatable USPs: Powerful Factory, Quality Assurance, OEM/ODM Design, High-Speed Delivery.
- Cost Savings: 30-50% lower than competitors via China's optimized supply chain – grams at $500/g, tons at scale pricing.
- Superior Quality: >99% purity (HPLC), full DMF/FDA compliance, university-lab validated.
- Customization: OEM/ODM for 100+ analogs, 4-week turnaround.
- Fast Delivery: 7-14 days to USA via optimized logistics, 80% cost reduction.
- Scalability: Grams to tons, flexible MOQs.
- Service Excellence: 24/7 support, free re-testing.
| Parameter | Specification | Test Method |
|---|---|---|
| Purity | >99% (HPLC) | USP <621> |
| δ-Selectivity | >100x over μ/κ | Radioligand Binding |
| Batch Size | 1g - 100kg+ | Custom |
| Certifications | GMP, DMF, FDA | ISO 9001 |
| Lead Time | 7-14 days USA | DDP Incoterms |
μ-opioid receptor agonist κ-opioid receptor agonist delta opioid receptor agonist
Real-World Applications & Case Studies
- Neuropathic Pain Research: USA pharma client reduced EC50 variability by 60% using our agonist in CCI models.
- Neuroprotection Studies: Stroke model infarct reduction of 45% validated in NIH grant project.
- Custom Peptide SAR: Delivered 50 analogs in 6 weeks for depression pipeline acceleration.
Frequently Asked Questions on Wholesale δ-Opioid Receptor Agonist
How do I buy bulk δ-opioid receptor agonist for USA delivery?
Contact us via form, WhatsApp, or email for a quote. We handle DDP Incoterms, FDA-compliant docs.
What customization options for OEM/ODM δ-agonists?
Full SAR design, deuterated/fluorescent labels, 4-week TAT from your specs.
What are shipping times and costs to USA?
7-14 days, 80% cheaper than standard – free quote includes all fees.
Is it GMP-certified for research?
Yes, with DMF, COA, and FDA export compliance for R&D use.
What after-sales support do you offer?
Free re-testing, 1-year stability data, priority resupply.
Minimum order quantity?
1g for samples, scalable to tons.
Payment methods accepted?
T/T, L/C, escrow for USA buyers – 30% advance, balance post-COa.
Uses and compliance?
Strictly for research; complies with USA import regs, no human use claims.
Reduce Costs by 30% in 90 Days – Risk-Free with Free Samples
Limited stock alert: First 10 USA inquiries get free 1g sample + priority shipping. Money-back guarantee on purity.
Full Contact | Privacy Policy Protected
Real User Reviews from USA Customers
"Outstanding quality δ-agonist. Saved us $15K on our last order vs. EU supplier. Highly recommend!"
– Mike R., Supply Chain Mgr., Texas Lab ★★★★★
"Fast OEM delivery, perfect for our pain research. GMP docs sped up our compliance review."
– Dr. Emily T., Technical Director, NY Pharma ★★★★★
"Best service – free sample led to bulk order. Shipping to CA was half the cost, twice the speed."
– Ops Mgr. James K., Biotech Firm ★★★★★
"Reliable partner for peptides. Quality beat competitors; will reorder for neuroprotection studies."
– Lisa M., Purchasing Lead, Florida Research ★★★★★
"Top-notch δ-agonist purity. Transformed our assay reproducibility. Global Tech is our go-to."
– Robert S., Director, Midwest Univ. Lab ★★★★★About the Author
Dr. Alex Chen, PhD
Senior R&D Director at Global Technology Co., Ltd with 20+ years in peptide API development. Former lead chemist at a top-10 USA pharma, published 50+ papers on opioid receptor ligands (e.g., J. Med. Chem.). Expert in GMP scaling for δ-opioid agonists, advising FDA IND submissions.
Tel: +86 19943830844 | Email: service@huanqiukeji9.com
Company: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Contact Us
Global Technology Co., Ltd – Leading Exporter of Research Chemicals, Steroids, Peptides, Pharmaceutical Intermediates. All products for research use only, compliant with USA regulations.
Proven Trust: Factory, Clients, and Certifications
Trusted by Leading USA Pharma & Research Labs
Global Certifications